MeSH term
Frequency | Condition_Probility | Humans | 29 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Animals | 11 | 0.0 |
Base Sequence | 7 | 0.0 |
Cell Line | 4 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Radioligand Assay | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
In Vitro | 2 | 0.0 |
Mice | 8 | 0.0 |
Somatostatin/pharmacology | 2 | 4.0 |
Male | 10 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
RNA, Messenger/analysis/genetics | 3 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Child | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Protein Precursors/*genetics | 2 | 1.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Rats | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Comparative Study | 7 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Aged | 3 | 0.0 |
Female | 10 | 0.0 |
Middle Aged | 5 | 0.0 |
Biopsy | 2 | 0.0 |
Adult | 3 | 0.0 |
Genetic Markers | 2 | 0.0 |
Body Mass Index | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Somatostatin/*genetics | 2 | 50.0 |
Prognosis | 2 | 0.0 |
Sialyltransferases/*blood | 2 | 66.0 |
Transferases/*blood | 2 | 50.0 |
